poor or suboptimal ovarian response,GnRH agonist long protocol
Showing 1 - 25 of >10,000
Ovarian Stimulation, Human Chorionic Gonadotropin, Oocyte Donors Trial in Thessaloniki (Dual trigger (human chorionic
Recruiting
- Ovarian Stimulation
- +2 more
- Dual trigger (human chorionic gonadotropin plus GnRH-agonist)
- GnRH-agonist only trigger
-
Thessaloniki, GreeceEmbryolab Fertility Clinic
Nov 20, 2023
Infertility, Female Trial in Worldwide (FE 999049 + GnRH agonist (GONAPEPTYL), FE 999049 + GnRH antagonist (CETROTIDE))
Completed
- Infertility, Female
- FE 999049 + GnRH agonist (GONAPEPTYL)
- FE 999049 + GnRH antagonist (CETROTIDE)
-
Dobl, Austria
- +15 more
Sep 28, 2022
In Vitro Fertilization Trial (Org 36286 (corifollitropin alfa))
Completed
- In Vitro Fertilization
- Org 36286 (corifollitropin alfa)
- (no location specified)
Feb 1, 2022
Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility Trial (ultrashort GnRHa, short GnRHa, long GnRHa)
Not yet recruiting
- Intracytoplasmic Sperm Injection
- +3 more
- ultrashort GnRHa
- +2 more
- (no location specified)
Oct 2, 2022
Fertility Trial in Barcelona (150µg CFA (Elonva®) at stimulation day (SD) 1 and 100µg CFA(Elonva®) at SD 5, 150µg CFA (Elonva®)
Not yet recruiting
- Fertility
- 150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5
- 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger
-
Barcelona, SpainHospital Universitario Quiron Dexeus
Nov 10, 2023
IVF, PCO Trial in Bani Suwayf (Dydrogesterone Tablets, Cetrorelix)
Not yet recruiting
- IVF
- PCO
- Dydrogesterone Tablets
- Cetrorelix
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 16, 2023
Endometriosis Trial (surveys (Fertiqol et SF36))
Not yet recruiting
- Endometriosis
- surveys (Fertiqol et SF36)
- (no location specified)
Oct 26, 2023
Infertility, Female Trial in Giza (Growth hormone/HPuFSH/GnRH antagonist, HPuFSH/GnRH antagonist)
Unknown status
- Infertility, Female
- Growth hormone/HPuFSH/GnRH antagonist
- HPuFSH/GnRH antagonist
-
Giza, EgyptRiyadh Fertility and Reproductive Health center
May 24, 2020
Adenomyosis Trial in France (11.25mg GnRH agonist, 0.1 mg GnRH agonist, 25 µg transdermal oestradiol)
Withdrawn
- Adenomyosis
- 11.25mg GnRH agonist
- +2 more
-
Angers, France
- +13 more
Nov 14, 2022
In Vitro Fertilization, ICSI Intracytoplasmic Spermatozoid Injection Trial in Bondy (Ovulation induction with hCG + Luteal phase
Not yet recruiting
- In Vitro Fertilization
- ICSI Intracytoplasmic Spermatozoid Injection
- Ovulation induction with hCG + Luteal phase support with vaginal progesterone
- Ovulation triggering by Triptorelin + Luteal phase support by Nafarelin
-
Bondy, FranceMaeliss Peigné
Nov 27, 2023
Ovarian Response in Oocyte Donors Triggered With GnRH Agonists
Completed
- Poor Response to Ovulation Induction
-
Barcelona, SpainClinica EUGIN
Jul 20, 2022
Infertility Trial in Barcelona (Ovarian Stimulation with CC+rFSH, Ovarian Stimulation with rFSH)
Recruiting
- Infertility
- Ovarian Stimulation with CC+rFSH
- Ovarian Stimulation with rFSH
-
Barcelona, SpainSalud de la Mujer Dexeus
Jan 10, 2022
Infertility Trial (10000 IU hCG (Choriomon5000 IU; IBSA), Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring))
Not yet recruiting
- Infertility
- 10000 IU hCG (Choriomon5000 IU; IBSA)
- Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring)
- (no location specified)
May 27, 2022
Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer Trial in Barcelona (Somatropin)
Terminated
- Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer
-
Barcelona, SpainDepartamento de Obstetricia Ginecologia y Reproducción. Institut
Feb 10, 2020
Ovarian Hyperstimulation Syndrome, Infertility, Female Trial in Toronto (Pregnyl (1,500) IU, 1.5 mL of normal saline)
Recruiting
- Ovarian Hyperstimulation Syndrome
- Infertility, Female
- Pregnyl (1,500) IU
- 1.5 mL of normal saline
-
Toronto, Ontario, CanadaMount Sinai Hospital, Fertility Clinic
Dec 9, 2022
IVF Trial in Bani Suwayf (Dydrogesterone, Cetrorelix acetate, Triptorelin)
Recruiting
- IVF
- Dydrogesterone
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Aug 1, 2023
Infertility, Diminished Ovarian Reserve, IVF Trial in Manhasset (Timing of injectable gonadotropins)
Recruiting
- Infertility
- +2 more
- Timing of injectable gonadotropins
-
Manhasset, New YorkNorthwell Fertility
Sep 29, 2022
Adenomyosis Trial in Modena (Enantone, Dienogest 2 MG (milligram), long GnRH agonist or flexible GnRH antagonist protocol.)
Recruiting
- Adenomyosis
- Enantone
- +2 more
-
Modena, ItalyAzienda Ospedaliero-Universitaria di Modena
Jul 6, 2023
Sterility Trial in China (GnRH-ant protocol, GnRH-a long protocol)
Unknown status
- Sterility
- GnRH-ant protocol
- GnRH-a long protocol
-
Beijing, Beijing, China
- +3 more
Nov 6, 2019
In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility Trial in Damascus (Triptorelin acetate, Cetrorelix,
Recruiting
- In Vitro Fertilization
- +2 more
- Triptorelin acetate
- +3 more
-
Damascus, Syrian Arab RepublicOrient Hospital
Aug 17, 2021
In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection Trial in Damascus (Triptorelin acetate, Cetrorelix,
Recruiting
- In Vitro Fertilization
- +3 more
- Triptorelin acetate
- +3 more
-
Damascus, Syrian Arab RepublicOrient Hospital
Aug 17, 2021
IVF Trial (Progesterone 200 MG, Ganirelix Acetate)
Not yet recruiting
- IVF
- Progesterone 200 MG
- Ganirelix Acetate
- (no location specified)
Jul 12, 2023
Infertility, Female Trial in Alexandria (Duphaston, Gonadotropin, Cetrotide Injectable Product)
Completed
- Infertility, Female
- Duphaston
- +7 more
-
Alexandria, EgyptElshatby University Maternity Hospital
Jan 26, 2022